C9orf72 and frontotemporal dementia: Consequently, in light of pharmacological advantages, small molecules targeting G-quadruplexes formed by C9orf72 HRE G4C2 DNA/RNA offer an attractive option as a therapeutic approach for ALS/FTD and several novel compounds have been reported in patient-derived neurons (9,57).